Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), BRAF, Liquid biopsy (ctDNA), Nivolumab and the tag subtype-page.
Shares Tumour mutational burden (TMB), Tumour-agnostic (tissue-agnostic) approval, Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Histopathology & immunohistochemistry and the tag subtype-page.
Shares Tumour-agnostic (tissue-agnostic) approval, Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Liquid biopsy (ctDNA), Nivolumab and the tag subtype-page.
Shares Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Histopathology & immunohistochemistry, BRAF, HER2 and the tag subtype-page.
Shares Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Histopathology & immunohistochemistry, Paclitaxel / nab-paclitaxel, Carboplatin and the tag subtype-page.
Shares Histopathology & immunohistochemistry, Paclitaxel / nab-paclitaxel, Carboplatin, Pembrolizumab and the tag subtype-page.
Shares Liquid biopsy (ctDNA), Nivolumab, PD-1, Pembrolizumab and the tag subtype-page.
Shares Histopathology & immunohistochemistry, HER2, Paclitaxel / nab-paclitaxel, Carboplatin and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-18. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.